JOSHUA WINGFIELD: Open Payments
NPI 1144508938 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 15 payments from 8 companies in 2025. Trend: 2023 $315 · 2024 $388 · 2025 $522
Food & beverage: $482Education: $40
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $172 |
| Shionogi Inc | 1 | $105 |
| Astellas Pharma US Inc | 4 | $93 |
| Paratek Pharmaceuticals, Inc. | 2 | $51 |
| Invivyd Inc | 2 | $45 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Cumberland Pharmaceuticals, Inc. | 1 | $18 |
Products named: EMBLAVEO, Fetroja, Cresemba, NUZYRA, PEMGARDA, DALVANCE, MAVYRET, ZERBAXA.
Industry payments across PA — which companies pay providers there.
